17 March 2025 : Clinical Research
Predictive Value of Platelet Aggregation Tests in Recurrent Cerebral Ischemia and Major Bleeding
Masanori Ishiguro ABCDEF 1, Yasutaka Kurokawa
ACDEF 2*, Atsushi Tanooka B 3, Takashi Nagamine D 1
DOI: 10.12659/MSM.947172
Med Sci Monit 2025; 31:e947172
Figure 2 Change in maximal aggregation (MaxAgg) is summarized according to the presence of ischemic recurrence in the patients treated with aspirin. In the control group, MaxAgg remained unchanged (left) by both concentrations of adenosine diphosphate (ADP) stimulation, even between 2 different intervals. MaxAgg decreased significantly in patients without recurrence by stimulation of both concentrations (middle). On the contrary, MaxAgg did not decrease in patients with recurrence (right).